Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 34, 2007, Pages 13732-13737

  Lee, Sangkyou ^a   Jeong, Joon ^a   Majewski, Tadeusz ^a   Scherer, Steven E ^b   Kim, Mi Sook ^a   Tuziak, Tomasz ^a   Tang, Kuang S ^a   Baggerly, Keith ^a   Grossman, Herbert Barton ^a   Zhou, Jain Hua ^a   Shen, Lanlan ^a   Bondaruk, Jolanta ^a   Ahmed, Saira S ^a   Samanta, Susmita ^a   Spiess, Philippe ^a   Wu, Xifeng ^a   Filipek, Slawomir ^c   McConkey, David ^a   Bar Eli, Menashe ^a   Issa, Jean Pierre ^a   Benedict, William F ^a   Czerniak, Bogdan ^a   more..

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

Bladder cancer; Single nucleotide polymorphic sites; Whole organ histologic and genetic mapping

Indexed keywords

BH3 PROTEIN; COMPLEMENTARY DNA; DNA; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; PROTEIN BCL 2; RAS PROTEIN; RETINOBLASTOMA PROTEIN; PURINE P2 RECEPTOR;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GRADING; CANCER SUSCEPTIBILITY; CARCINOMA IN SITU; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE MAPPING; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; P2RY5 GENE; POINT MUTATION; PRIORITY JOURNAL; RB1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE; WHOLE ORGAN HISTOLOGIC AND GENETIC MAPPING; BLADDER TUMOR; CHEMICAL STRUCTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOSITY LOSS; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE;

BASE SEQUENCE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; MODELS, MOLECULAR; POLYMORPHISM, GENETIC; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PURINERGIC P2; RETINOBLASTOMA PROTEIN; URINARY BLADDER NEOPLASMS;

EID: 35348915886     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0701771104     Document Type: Article

References (30)

1. Carethers JM (1996) Gastroenterol Clin North Am 25:737-754.
2. Ilyas M, Straub J, Tomlinson IP, Bodmer WF (1999) Eur J Cancer 35:335-351.
3. Watanabe T, Muto T (2000) World J Surg 24:1091-1097.
4. Ayala AG, Ro JY, Amin M, Czerniak B, Albores-Saavedra J (2001) in Pathology of Incipient Neoplasia, eds Henson DE, Albores-Saavedra J (Oxford Univ Press, New York), pp 483-534.
5. Dinney CP, McConkey DJ, Millikan RE, Wu X, Bar-Eli M, Adam L, Kamat AM, Siefker-Radtke AO, Tuziak T, Sabichi AL, et al. (2004) Cancer Cell 6:111-116.
6. Chaturvedi V, Li L, Hodges S, Johnston D, Ro JY, Logothetis C, von Eschenbach AC, Batsakis JG, Czerniak B (1997) Oncogene 14:2059-2070.
7. Czerniak B, Chaturvedi V, Li L, Hodges S, Johnston D, Roy JY, Luthra R, Logothetis C, Von Eschenbach AC, Grossman HB, et al. (1999) Oncogene 18:1185-1196.
8. Czerniak B, Li L, Chaturvedi V, Ro JY, Johnston DA, Hodges S, Benedict WF (2000) Genes Chromosomes Cancer 27:392-402.
9. Spiess PE, Czerniak B (2006) Arch Pathol Lab Med 130:844-852.
10. Gazdar AF, Czerniak B (2001) J Natl Cancer Inst 93:413-415.
11. Koss LG, Tiamson EM, Robbins MA (1974) J Am Med Assoc 227:281-286.
12. Knowles MA (2006) Carcinogenesis 27:361-373.
13. Kim MS, Jeong J, Majewski T, Kram A, Yoon DS, Zhang RD, Li JZ, Ptaszynski K, Kuang TC, Zhou JH, et al. (2006) Lab Invest 86:175-190.
14. Tuziak T, Jeong J, Majewski T, Kim MS, Steinberg J, Wang Z, Yoon DS, Kuang TC, Baggerly K, Johnston D, et al. (2005) Lab Invest 85:689-701.
15. Fleischer A, Ayllon V, Dumoutier L, Renauld JC, Rebollo A (2002) Oncogene 21:3181-3189.
16. Devilder MC, Cadoret E, Cherel M, Moreau I, Rondeau G, Bezieau S, Moisan JP (1998) Genomics 54:99-106.
17. Adrian K, Bernhard MK, Breitinger HG, Ogilvie A (2000) Biochim Biophys Acta 1492:127-138.
18. Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M (1995) Proteins 23:318-326.
19. Okada T, Sugihara M, Bondar AN, Elstner M, Entel P, Buss V (2004) J Mol Biol 342:571-583.
20. Bowie JU, Luthy R, Eisenberg D (1991) Science 253:164-170.
21. Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, Engel A (2003) J Biol Chem 278:21655-21662.
22. Filipek S, Krzysko KA, Fotiadis D, Liang Y, Saperstein DA, Engel A, Palczewski K (2004) Photochem Photobiol Sci 3:628-638.
23. Oldham WM, Van Eps N, Preininger AM, Hubbell WL, Hamm HE (2006) Nat Struct Mol Biol 13:772-777.
24. Letai A (2006) Cancer Cell 10:343-345.
25. Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni JF, Jr (2005) J Clin Oncol 23:2272-2279.
26. Oka K, Tomonaga Y, Nakazawa T, Ge HY, Bengtsson U, Stanbridge EJ, Yoshioka N, Li Q, Hakura A, Yutsudo M (1999) Genes Chromosomes Cancer 26:47-53.
27. De la Vega FM, Lazaruk KD, Rhodes MD, Wenz MH (2005) Mutat Res 573:111-135.
28. Kader AK, Shao L, Dinney CP, Schabath MB, Wang Y, Liu J, Gu J, Grossman HB, Wu X (2006) Cancer Res 66:11644-11648.
29. Benedict WF, Lerner SP, Zhou J, Shen X, Tokunaga H, Czerniak B (1999) Oncogene 18:1197-1203.
30. Nawrocki ST, Carew JS, Pino MS, Highshaw RA, Andtbacka RH, Dunner K, Jr, Pal A, Bornmann WG, Chiao PJ, Huang P, et al. (2006) Cancer Res 66:3773-3781.